Found 7 matching trials
Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor
PHASE1The purpose of this study is to determine whether autologous T cells bearin...
Location
PersonGen Biomedicine (Suzhou) Co., Ltd.
CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor
PHASE1This is a single-arm, open-label, one center clinical study, to determine t...
Location
Ningbo No.5 Hospital (Ningbo Cancer Hospital)
CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor
PHASE1The purpose of this study is to evaluate the safety and effectiveness of CA...
Location
PersonGen Biomedicine (Suzhou) Co., Ltd.
Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
PHASE1This is a multicenter, open-label, Phase 1/2 master protocol evaluating aut...
Location
Peking University Shenzhen Hospital
Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC
PHASE1The study is to assess the safety and efficacy of the anti-MUC1 CAR T cells...
Location
First Affiliated Hospital of Guangdong Pharmaceutical University
PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer
PHASE1This exploratory clinical study aims to assess the safety and preliminary e...
Location
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer
PHASE1The study is to assess the safety and efficacy of the immunotherapies using...
Location
First Affiliated Hospital of Guangdong Pharmaceutical University